We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

112 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more call options, than puts

Call options by funds: $2.41M | Put options by funds: $1.19M

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

2.21% more ownership

Funds ownership: 33.22% → 35.44% (+2.2%)

1% more funds holding

Funds holding: 111 → 112 (+1)

1% less capital invested

Capital invested by funds: $125M → $123M (-$1.86M)

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

Holders
112
Holders Change
+1
Holders Change %
+0.9%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
16
Increased
21
Reduced
25
Closed
12
Calls
$2.41M
Puts
$1.19M
Net Calls
+$1.22M
Net Calls Change
+$2.75M

Top Buyers

Rank Fund Capital Flow
1
AA
Ascent Advisors
Minnesota
+$11.5M
2
Bank of America
Bank of America
North Carolina
+$3.93M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.83M
4
CCA
Conservest Capital Advisors
Pennsylvania
+$729K
5
Wells Fargo
Wells Fargo
California
+$667K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$5.03M
2
Corient Private Wealth
Corient Private Wealth
Florida
-$1.9M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.1M
4
LPL Financial
LPL Financial
California
-$1.01M
5
UBS Group
UBS Group
Switzerland
-$690K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
76
Manchester Capital Management
Vermont
$56.4K – – –
SS
77
SBI Securities
Japan
$54.2K – – –
Bank of Montreal
78
Bank of Montreal
Ontario, Canada
$54K – – –
MCM
79
MAI Capital Management
Ohio
$49.8K – – –
Carson Wealth (CWM LLC)
80
Carson Wealth (CWM LLC)
Nebraska
$42.3K – – –
William Blair & Company
81
William Blair & Company
Illinois
$42.3K – – –
TC
82
Truvestments Capital
Florida
$41.4K – – –
T
83
Tidemark
California
$38.9K – – –
NSIM
84
North Star Investment Management
Illinois
$38.4K – – –
CT
85
Caldwell Trust
Florida
$36.1K – – –
CT
86
Coastline Trust
Rhode Island
$35.7K – – –
CA
87
CoreCap Advisors
Michigan
$35.7K – – –
HI
88
Harbour Investments
Wisconsin
$34.2K -$2.5K -13 -7%
BlackRock
89
BlackRock
New York
$31K – – –
AIM
90
Anchor Investment Management
South Carolina
$30.1K – – –
JWA
91
JFS Wealth Advisors
Pennsylvania
$28.2K +$28.9K +150 New
OSAM
92
O'Shaughnessy Asset Management
Connecticut
$21.2K – – –
FCMT
93
Founders Capital Management (Texas)
Texas
$18.8K – – –
WT
94
Whittier Trust
California
$18.7K – – –
FP
95
Financial Perspectives
Minnesota
$16.5K – – –
HWM
96
HighMark Wealth Management
Minnesota
$15K – – –
1NWS
97
1 North Wealth Services
Maryland
$14.8K – – –
IAAG
98
Innovative Asset Advisors Group
Connecticut
$14.1K +$14.5K +75 New
LFG
99
Larson Financial Group
Missouri
$13.2K – – –
SG
100
Sankala Group
Colorado
$12.3K -$3.66K -19 -22%
1 2 3
4
5

BBH Hedge Fund Activity: Q1 2026 in Review

112 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2026, worth a combined $123M — down 1.5% from $125M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BBH positions and 12 closed out — a net gain of 4 holders — while 21 added to existing stakes and 25 trimmed.

The largest buyer was Ascent Advisors, opening a new position worth an estimated $11.5M. The largest seller was Morgan Stanley, cutting an estimated $5.03M.

  • 112 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2026, up from 111 in Q4 2025.
  • Funds reported $123M of VanEck Biotech ETF stock for Q1 2026, down 1.5% quarter-over-quarter.
  • 16 funds opened new VanEck Biotech ETF positions in Q1 2026 and 12 closed out, a net change of +4 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2026 was Ascent Advisors, an estimated $11.5M added.
  • The largest VanEck Biotech ETF seller in Q1 2026 was Morgan Stanley, an estimated $5.03M sold.

Based on aggregated 13F filings for Q1 2026.